These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1063 related articles for article (PubMed ID: 19567783)
1. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells. Ushio K; Hashimoto T; Kitamura N; Tanaka T Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation. Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740 [TBL] [Abstract][Full Text] [Related]
3. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression. Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line. Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway. Wang Z; Ge L; Wang M; Carr BI J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619 [TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414 [TBL] [Abstract][Full Text] [Related]
7. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990 [TBL] [Abstract][Full Text] [Related]
8. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells. Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells. Han J; Tsukada Y; Hara E; Kitamura N; Tanaka T J Biol Chem; 2005 Sep; 280(36):31548-56. PubMed ID: 16014626 [TBL] [Abstract][Full Text] [Related]
10. Involvement of Egr-1 in HGF-induced elevation of the human 5alpha-R1 gene in human hepatocellular carcinoma cells. Rui C; Li C; Xu W; Zhan Y; Li Y; Yang X Biochem J; 2008 Apr; 411(2):379-86. PubMed ID: 18215136 [TBL] [Abstract][Full Text] [Related]
11. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401 [TBL] [Abstract][Full Text] [Related]
12. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520 [TBL] [Abstract][Full Text] [Related]
13. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882 [TBL] [Abstract][Full Text] [Related]
14. Expression of genes involved in the regulation of p16 in psoriatic involved skin. Mark EB; Jonsson M; Asp J; Wennberg AM; Mölne L; Lindahl A Arch Dermatol Res; 2006 Apr; 297(10):459-67. PubMed ID: 16552541 [TBL] [Abstract][Full Text] [Related]
15. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Jiang Y; Xu W; Lu J; He F; Yang X Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416 [TBL] [Abstract][Full Text] [Related]
16. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the cell type specific induction of SnoN expression by hepatocyte growth factor. Tan R; Zhang X; Yang J; Li Y; Liu Y J Am Soc Nephrol; 2007 Aug; 18(8):2340-9. PubMed ID: 17625116 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Matsushita A; Götze T; Korc M Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Marampon F; Ciccarelli C; Zani BM Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113 [TBL] [Abstract][Full Text] [Related]
20. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]